Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

GMP in Latin America (ANVISA, COFEPRIS)

How to Prepare for an ANVISA GMP Inspection in Brazil

Posted on December 9, 2024 By digi

How to Prepare for an ANVISA GMP Inspection in Brazil How to Prepare for an ANVISA GMP Inspection in Brazil Introduction to ANVISA GMP Inspections In Brazil, the National Health Surveillance Agency (ANVISA) is the regulatory authority responsible for ensuring the safety, efficacy, and quality of pharmaceutical products. One of the key aspects of maintaining…

Read More “How to Prepare for an ANVISA GMP Inspection in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

The Role of COFEPRIS GMP Guidelines in Clinical Trials in Latin America

Posted on December 9, 2024 By digi

The Role of COFEPRIS GMP Guidelines in Clinical Trials in Latin America The Role of COFEPRIS GMP Guidelines in Clinical Trials in Latin America Introduction to COFEPRIS and GMP in Clinical Trials In Latin America, the regulatory environment for clinical trials plays a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products….

Read More “The Role of COFEPRIS GMP Guidelines in Clinical Trials in Latin America” »

GMP in Latin America (ANVISA, COFEPRIS)

How ANVISA GMP Standards Ensure Product Quality in Brazilian Pharma Manufacturing

Posted on December 8, 2024 By digi

How ANVISA GMP Standards Ensure Product Quality in Brazilian Pharma Manufacturing How ANVISA GMP Standards Ensure Product Quality in Brazilian Pharma Manufacturing Introduction to ANVISA and Its Role in Pharmaceutical Manufacturing The pharmaceutical industry in Brazil plays a significant role in both the local and global healthcare markets. Ensuring the quality of drugs manufactured within…

Read More “How ANVISA GMP Standards Ensure Product Quality in Brazilian Pharma Manufacturing” »

GMP in Latin America (ANVISA, COFEPRIS)

How to Achieve GMP Compliance According to ANVISA and COFEPRIS Guidelines

Posted on December 8, 2024 By digi

How to Achieve GMP Compliance According to ANVISA and COFEPRIS Guidelines How to Achieve GMP Compliance According to ANVISA and COFEPRIS Guidelines Introduction to GMP Compliance in Latin America Good Manufacturing Practices (GMP) are crucial for ensuring the safety, quality, and efficacy of pharmaceutical products. In Latin America, both ANVISA (Brazil’s National Health Surveillance Agency)…

Read More “How to Achieve GMP Compliance According to ANVISA and COFEPRIS Guidelines” »

GMP in Latin America (ANVISA, COFEPRIS)

The Role of ANVISA GMP Regulations in Pharmaceutical R&D in Latin America

Posted on December 7, 2024 By digi

The Role of ANVISA GMP Regulations in Pharmaceutical R&D in Latin America The Role of ANVISA GMP Regulations in Pharmaceutical R&D in Latin America Introduction to ANVISA GMP and Pharmaceutical R&D in Latin America In Latin America, pharmaceutical research and development (R&D) are vital to the advancement of healthcare and the introduction of new treatments…

Read More “The Role of ANVISA GMP Regulations in Pharmaceutical R&D in Latin America” »

GMP in Latin America (ANVISA, COFEPRIS)

COFEPRIS GMP Guidelines for Drug Safety and Quality in Mexico

Posted on December 6, 2024 By digi

COFEPRIS GMP Guidelines for Drug Safety and Quality in Mexico COFEPRIS GMP Guidelines for Drug Safety and Quality in Mexico Introduction to COFEPRIS and GMP Guidelines In Mexico, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the regulatory body responsible for overseeing pharmaceutical products, ensuring that they meet the highest standards of…

Read More “COFEPRIS GMP Guidelines for Drug Safety and Quality in Mexico” »

GMP in Latin America (ANVISA, COFEPRIS)

How ANVISA GMP Compliance Affects Drug Manufacturing in Brazil

Posted on December 6, 2024 By digi

How ANVISA GMP Compliance Affects Drug Manufacturing in Brazil How ANVISA GMP Compliance Affects Drug Manufacturing in Brazil Introduction to ANVISA GMP Compliance and Its Impact on Drug Manufacturing The pharmaceutical industry in Brazil is regulated by the National Health Surveillance Agency (ANVISA), which ensures the safety, efficacy, and quality of drugs manufactured within the…

Read More “How ANVISA GMP Compliance Affects Drug Manufacturing in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

COFEPRIS GMP Regulations: What Mexican Pharma Companies Need to Know

Posted on December 5, 2024 By digi

COFEPRIS GMP Regulations: What Mexican Pharma Companies Need to Know COFEPRIS GMP Regulations: What Mexican Pharma Companies Need to Know Introduction to COFEPRIS and GMP Regulations In Mexico, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) plays a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products. COFEPRIS enforces Good…

Read More “COFEPRIS GMP Regulations: What Mexican Pharma Companies Need to Know” »

GMP in Latin America (ANVISA, COFEPRIS)

Understanding ANVISA GMP Guidelines for Pharmaceutical Manufacturers in Brazil

Posted on December 5, 2024 By digi

Understanding ANVISA GMP Guidelines for Pharmaceutical Manufacturers in Brazil Understanding ANVISA GMP Guidelines for Pharmaceutical Manufacturers in Brazil Introduction to ANVISA and GMP Guidelines The pharmaceutical industry in Brazil is regulated by the National Health Surveillance Agency (ANVISA), which enforces Good Manufacturing Practices (GMP) to ensure that drugs are produced safely, effectively, and in compliance…

Read More “Understanding ANVISA GMP Guidelines for Pharmaceutical Manufacturers in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

Posts pagination

Previous 1 … 4 5

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Qualify HVAC Systems in Warehouses to Maintain GMP Storage Conditions

    Qualify HVAC Systems in Warehouses… Read more

GMP in Latin America (ANVISA, COFEPRIS)

  • The Importance of ANVISA GMP Compliance for Pharmaceutical Manufacturers in Latin America
  • How to Integrate ANVISA and COFEPRIS GMP Guidelines into Your Pharmaceutical QMS
  • The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance
  • How ANVISA GMP Regulations Influence the Production of Vaccines
  • How COFEPRIS GMP Ensures the Quality of Biological Drugs
  • How to Achieve GMP Compliance for Pharmaceutical Packaging in Brazil
  • How ANVISA GMP Guidelines Support Sustainable Manufacturing Practices in Brazil
  • How COFEPRIS GMP Supports the Manufacturing of Orphan Drugs
  • How ANVISA GMP Guidelines Ensure Compliance for Pharmaceutical Exports
  • COFEPRIS GMP and the Role of Biopharmaceutical Manufacturing in Mexico

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme